• About us
• Contact

Advertisement

Organisation › Details

ZoBio B.V.

ZoBio uses fragment-based drug discovery to provide validated, biologically active compounds against challenging drug targets. Screening of our or a client’s library can be accomplished using our proprietary Target Immobilized NMR Screening (TINS) platform and/or high-throughput SPR using our Biacore 4000. We then integrate industry standard Biacore and unique, novel biophysical approaches and biochemical assays with our NMR Pyramid technology to validate ligands and provide structural insight into their interaction with the target. ZoBio is dedicated to providing its clients the best science and compounds in a manner that fits within their workflow. *

 

	Start	2004-01-01 splitoff
	Predecessor	University of Leiden (NL)
	Industry	drug screening (HTS)
	Industry 2	NMR spectroscopy
	Person	Siegal, Gregg (ZoBio 201412 CEO)
	Region	Leiden
	Country	Netherlands
	Street	55 Einsteinweg
	City	2333 CC Leiden
	Tel	+31-71-527-4543
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.